A Speedinvest portfolio company

Rivia

Year Invested
2024
AI-driven analytics and data infrastructure for successful Biopharma clinical trials

Rivia addresses inefficiencies in biopharma clinical trials, where fragmented data and outdated tools hinder the development of new therapies. Their technology offers a real-time, integrated view of data to improve the evaluation of new treatments and trial conduct. Their vision is to become the unified data infrastructure that transforms clinical development lifecycles, bringing new therapies to market more successfully.

https://rivia.ch/
Hi, we're Speedinvest

Proud partners with Europe's most visionary founders who are redefining technology's role in our daily lives.

Tell us about your startup